Inflammatory exposure and historical changes in human life-spans

Science

Volumn 305, Issue 5691, 2004, Pages 1736-1739

  Finch, Caleb E ^a   Crimmins, Eileen M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; HISTORY; REDUCTION; SOCIAL SCIENCES;

HEALTH FACTORS; INFLAMMATORY EXPOSURE; LIFE EXPECTANCY; MORBIDITY;

HEALTH CARE;

BIOLOGY;

AGING; BIRTH; COHORT ANALYSIS; EPIDEMIOLOGICAL DATA; FOOD INTAKE; HEALTH BEHAVIOR; HEALTH STATUS; HUMAN; INFECTION; INFLAMMATION; LIFE EXPECTANCY; LIFESPAN; MALNUTRITION; MORBIDITY; MORTALITY; NUTRITION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ADULT; AGED; CHILD; INFANT; LONGEVITY; TIME;

ADULT; AGED; CHILD; COHORT STUDIES; HUMANS; INFANT; INFECTION; INFLAMMATION; LIFE EXPECTANCY; LONGEVITY; MORBIDITY; MORTALITY; NUTRITION PHYSIOLOGY; TIME FACTORS;

EID: 4544322522     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1092556     Document Type: Review

References (30)

1. J. Oeppen, J. W. Vaupel, Science 296, 1029 (2002).
2. J. C. Riley, Rising Life Expectancy: A Global History (Cambridge Univ. Press, New York, 2001).
3. R. Floud, K. Wachter, A. Gregory, Eds., Height, Health, and History (Cambridge Univ. Press, New York, 1990).
4. I. T. Elo, S. H. Preston, Popul. Index 58, 186 (1992).
5. J. R. Wilmoth et al., Science 289, 2366 (2000).
6. J. T. Willerson, P. M. Ridker, Circulation 109 (suppl. 1), 112 (2004).
7. J. Zhu et al., Am. J. Cardiol. 85, 140 (2000).
8. J. L. Georges et al., Am. J. Cardiol. 92, 515 (2003).
9. J. C. Breitner, Lancet Neurol. 2, 527 (2003).
10. A. H. Vagnucci Jr., W. W. Li, Lancet 361, 605 (2003).
11. H. Jones, Adv. Biol. Med. Phys. 4, 281 (1956).
12. T. Bengtsson, M. Lindstrom, Int. J. Epidemiol. 32, 286 (2003).
13. D. L. Costa, Demography 37, 53 (2000).
14. S. O. Shaheen et al., Am. J. Respir. Crit. Care Med. 149, 616 (1994).
15. C. Buck, H. Simpson, J. Epidemiol. Community Health 36, 27 (1982).
16. D. L. Blackwell, M. D. Hayward, E. M. Crimmins, Soc. Sci. Med. 52, 1269 (2001).
17. W. O. Kermack, A. G. McKendrick, P. L. HcKinlay, Lancet 1, 698 (1934).
18. C. E. Finch, M. C. Pike, M. Witten, Science 249, 902 (1990).
19. E. M. Crimmins, C. E. Finch, unpublished data. A regression analysis of early mortality associations with later mortality by cohort versus period, for Sweden and other countries, shows the overall pattern summarized here for Sweden.
20. W. Palinski, C. Napoli, FASEB J. 16, 1348 (2002).
21. S. D. Lawn et al., Int. J. Tuberc. Lung Dis. 4, 340 (2000).
22. A. M. Cadwgan et al., J. Infect. 41, 159 (2000).
23. R. F. Harvey et al., Q. J. Med. 95, 519 (2002).
24. K. M. Kolltveit, L. Tronstad, I. Olsen, Clin. Microbiol. Rev. 13, 547 (2000).
25. G. Doblhammer, J. W. Vaupel, Proc. Natl. Acad. Sci. U.S.A. 98, 2934 (2001).
26. D. J. Barker, Trends Endocrinol. Metab. 13, 364 (2002).
27. V. Kannisto, K. Christensen, J. W. Vaupel, Am. J. Epidemiol. 145, 987 (1997).
28. R. J. Hunter et al., J. Nutrit. 131, 1513 (2001).
29. P. A. Sytkowski, W. B. Kannel, R. B. D'Agostino, N. Engl. J. Med. 322, 1635 (1990).
30. We thank A. Hagedorn and R. Vejella for data analysis and graphics, and B. Henderson, V. Longo, B. Teter, and A. Watts for helpful comments. Supported by National Institute on Aging (NIA) grants AG13499, AG05142, and AG14751 and the Alzheimer's Association (C.E.F.) and by NIA grant AG17265 (E.C.). C.E.F. is co-founder, stockholder, and member of the science advisory board of Acumen Pharmaceuticals Inc., which is developing treatments for Alzheimer's disease.